For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Operating costs and expenses | - | - | - | 1,186 |
| Revenues | 7,491 | 8,217 | 8,835 | 13,512 |
| Cost of revenues | 636 | 739 | 937 | 1,156 |
| Engineering and product development | 1,111 | 1,237 | 1,315 | - |
| Sales and marketing | 3,121 | 3,154 | 3,041 | 2,976 |
| Litigation contingency | - | - | 29,750 | - |
| General and administrative | 8,013 | 5,140 | 4,893 | 3,129 |
| Total operating expenses | 12,881 | 10,270 | 39,936 | 8,447 |
| (loss) income from operations | -5,390 | -2,053 | -31,101 | 5,065 |
| Other income | - | - | 4 | 5 |
| Interest (expense) income, net | -1,575 | -1,145 | -943 | - |
| Change in fair value of intangible digital assets | 28,490 | - | - | - |
| Interest and dividend income, operating | - | - | - | 168 |
| Change in fair value of bitcoin collateral | 1,471 | - | - | - |
| Change in fair value of intangible digital assets | - | 83,761 | -41,829 | 1,137 |
| Gain on redemption of notes receivable | 803 | - | - | - |
| Impairment of investments | - | - | 1,000 | - |
| Other income | 4 | - | - | - |
| Other income (expense), net | 29,193 | 82,616 | -43,768 | 1,310 |
| Pre-tax income | 23,803 | 80,563 | -74,869 | 6,375 |
| Income tax provision | 6,901 | 13,630 | -10,167 | 766 |
| Net income | 16,902 | 66,933 | -64,702 | 5,609 |
| Basic EPS | 1.14 | 5.71 | -6.74 | 0.8 |
| Diluted EPS | 1.07 | 5.04 | -6.74 | 0.72 |
| Basic Average Shares | 14,848,408 | 11,727,660 | 9,596,037 | 7,045,108 |
| Diluted Average Shares | 16,545,198 | 13,484,746 | 9,596,037 | 7,771,088 |
Semler Scientific, Inc. (SMLR)
Semler Scientific, Inc. (SMLR)